Andreia Albuquerque Cunha Lopes Morais, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cortical Spreading Depression | 16 | 2023 | 276 | 5.510 |
Why?
|
| Vagus Nerve Stimulation | 4 | 2022 | 199 | 1.340 |
Why?
|
| Hyperalgesia | 2 | 2023 | 502 | 1.240 |
Why?
|
| Migraine Disorders | 5 | 2023 | 1620 | 1.100 |
Why?
|
| Leukoaraiosis | 1 | 2022 | 120 | 0.770 |
Why?
|
| Migraine with Aura | 1 | 2020 | 203 | 0.640 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2023 | 1018 | 0.530 |
Why?
|
| Aneurysm, Ruptured | 1 | 2020 | 452 | 0.520 |
Why?
|
| Depression | 4 | 2023 | 7766 | 0.510 |
Why?
|
| Carthamus tinctorius | 2 | 2017 | 2 | 0.460 |
Why?
|
| Safflower Oil | 2 | 2017 | 29 | 0.460 |
Why?
|
| Lactation | 3 | 2017 | 412 | 0.450 |
Why?
|
| Behavior, Animal | 2 | 2020 | 1881 | 0.450 |
Why?
|
| Cerebral Hemorrhage | 2 | 2023 | 2647 | 0.430 |
Why?
|
| Intracranial Aneurysm | 1 | 2020 | 1197 | 0.390 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2023 | 8301 | 0.340 |
Why?
|
| Cerebral Cortex | 4 | 2019 | 5708 | 0.330 |
Why?
|
| Seizures | 1 | 2021 | 2859 | 0.320 |
Why?
|
| Animals | 26 | 2023 | 168757 | 0.320 |
Why?
|
| Rats | 10 | 2023 | 24260 | 0.300 |
Why?
|
| Rats, Wistar | 8 | 2019 | 1901 | 0.290 |
Why?
|
| Anxiety | 2 | 2020 | 4297 | 0.290 |
Why?
|
| Mice | 11 | 2023 | 81183 | 0.270 |
Why?
|
| Estrus | 1 | 2023 | 81 | 0.230 |
Why?
|
| Mefenamic Acid | 1 | 2022 | 5 | 0.210 |
Why?
|
| Antioxidants | 2 | 2014 | 1663 | 0.210 |
Why?
|
| Bicuculline | 1 | 2021 | 99 | 0.200 |
Why?
|
| Desoxycorticosterone | 1 | 2020 | 50 | 0.190 |
Why?
|
| Kainic Acid | 1 | 2021 | 199 | 0.190 |
Why?
|
| 4-Aminopyridine | 1 | 2021 | 81 | 0.190 |
Why?
|
| rho-Associated Kinases | 1 | 2022 | 279 | 0.190 |
Why?
|
| Potassium Channel Blockers | 1 | 2021 | 171 | 0.190 |
Why?
|
| Pancreatic Elastase | 1 | 2020 | 136 | 0.180 |
Why?
|
| Tetrodotoxin | 1 | 2021 | 259 | 0.180 |
Why?
|
| Mice, Inbred ICR | 1 | 2020 | 352 | 0.180 |
Why?
|
| Gene Knock-In Techniques | 1 | 2021 | 418 | 0.180 |
Why?
|
| Pain Threshold | 1 | 2023 | 584 | 0.170 |
Why?
|
| Inflammation | 1 | 2019 | 10638 | 0.170 |
Why?
|
| Guanosine | 1 | 2019 | 61 | 0.170 |
Why?
|
| Endothelin-1 | 1 | 2020 | 314 | 0.170 |
Why?
|
| Progesterone | 1 | 2023 | 776 | 0.170 |
Why?
|
| Disease Models, Animal | 4 | 2023 | 18029 | 0.160 |
Why?
|
| Hematoma | 1 | 2023 | 758 | 0.160 |
Why?
|
| Penicillins | 1 | 2021 | 380 | 0.160 |
Why?
|
| Laser-Doppler Flowmetry | 1 | 2018 | 242 | 0.160 |
Why?
|
| Mice, Inbred C57BL | 3 | 2020 | 21827 | 0.150 |
Why?
|
| Vagus Nerve | 1 | 2020 | 438 | 0.150 |
Why?
|
| Nervous System | 1 | 2021 | 554 | 0.150 |
Why?
|
| Corpus Callosum | 1 | 2022 | 737 | 0.150 |
Why?
|
| Mice, Transgenic | 2 | 2020 | 9734 | 0.150 |
Why?
|
| Dexamethasone | 1 | 2014 | 1951 | 0.150 |
Why?
|
| Overnutrition | 1 | 2016 | 26 | 0.150 |
Why?
|
| Ischemic Attack, Transient | 1 | 2023 | 935 | 0.150 |
Why?
|
| Male | 16 | 2023 | 350118 | 0.140 |
Why?
|
| Headache | 2 | 2022 | 1226 | 0.140 |
Why?
|
| Vitamins | 1 | 2014 | 1622 | 0.140 |
Why?
|
| Stroke | 3 | 2023 | 9981 | 0.140 |
Why?
|
| Estradiol | 1 | 2023 | 2020 | 0.130 |
Why?
|
| Brain Stem | 1 | 2021 | 846 | 0.130 |
Why?
|
| Brain | 6 | 2022 | 26385 | 0.130 |
Why?
|
| Fatty Acids, Omega-6 | 1 | 2016 | 227 | 0.130 |
Why?
|
| Oxidants | 1 | 2014 | 164 | 0.120 |
Why?
|
| Litter Size | 1 | 2013 | 54 | 0.110 |
Why?
|
| Light | 1 | 2018 | 1374 | 0.100 |
Why?
|
| Dentate Gyrus | 1 | 2013 | 160 | 0.100 |
Why?
|
| Recovery of Function | 1 | 2022 | 2925 | 0.100 |
Why?
|
| Motor Activity | 1 | 2012 | 2714 | 0.100 |
Why?
|
| Cell Shape | 1 | 2013 | 375 | 0.100 |
Why?
|
| Oxidative Stress | 2 | 2017 | 3086 | 0.100 |
Why?
|
| Lipid Peroxidation | 2 | 2017 | 270 | 0.100 |
Why?
|
| Maze Learning | 1 | 2013 | 478 | 0.100 |
Why?
|
| Ascorbic Acid | 1 | 2014 | 651 | 0.090 |
Why?
|
| Electric Stimulation | 1 | 2016 | 1767 | 0.090 |
Why?
|
| Calcium | 1 | 2013 | 5756 | 0.090 |
Why?
|
| Female | 10 | 2023 | 380194 | 0.090 |
Why?
|
| Models, Animal | 1 | 2016 | 2171 | 0.090 |
Why?
|
| Infarction, Middle Cerebral Artery | 2 | 2023 | 475 | 0.080 |
Why?
|
| Brain Ischemia | 1 | 2022 | 3265 | 0.080 |
Why?
|
| Malnutrition | 1 | 2014 | 625 | 0.080 |
Why?
|
| Catalase | 1 | 2017 | 222 | 0.070 |
Why?
|
| Sex Factors | 1 | 2020 | 10397 | 0.070 |
Why?
|
| Survival Rate | 1 | 2020 | 12788 | 0.070 |
Why?
|
| Phenotype | 1 | 2023 | 16365 | 0.070 |
Why?
|
| Memory Disorders | 1 | 2013 | 1184 | 0.070 |
Why?
|
| Glutathione | 1 | 2017 | 589 | 0.060 |
Why?
|
| Superoxide Dismutase | 1 | 2017 | 597 | 0.060 |
Why?
|
| Microglia | 1 | 2013 | 1266 | 0.060 |
Why?
|
| Calcimycin | 1 | 2013 | 222 | 0.060 |
Why?
|
| Body Weight | 3 | 2019 | 4669 | 0.060 |
Why?
|
| Myocardium | 1 | 2016 | 4776 | 0.060 |
Why?
|
| Aging | 1 | 2012 | 8664 | 0.060 |
Why?
|
| Rodentia | 1 | 2023 | 261 | 0.050 |
Why?
|
| Oxidation-Reduction | 1 | 2017 | 2187 | 0.050 |
Why?
|
| Sulfotransferases | 1 | 2022 | 151 | 0.050 |
Why?
|
| Liver | 1 | 2016 | 7474 | 0.050 |
Why?
|
| Random Allocation | 2 | 2016 | 2429 | 0.050 |
Why?
|
| Laboratories | 1 | 2023 | 463 | 0.040 |
Why?
|
| Animals, Newborn | 1 | 2014 | 2726 | 0.040 |
Why?
|
| Multicenter Studies as Topic | 1 | 2023 | 1677 | 0.040 |
Why?
|
| Electrophysiological Phenomena | 1 | 2019 | 315 | 0.040 |
Why?
|
| Weaning | 1 | 2016 | 105 | 0.040 |
Why?
|
| Plant Preparations | 1 | 2016 | 94 | 0.030 |
Why?
|
| Glucocorticoids | 1 | 2014 | 2107 | 0.030 |
Why?
|
| Malondialdehyde | 1 | 2014 | 105 | 0.030 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 1 | 2016 | 378 | 0.030 |
Why?
|
| Humans | 6 | 2023 | 744343 | 0.030 |
Why?
|
| Cerebrovascular Circulation | 1 | 2023 | 2731 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2022 | 5078 | 0.030 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2022 | 2282 | 0.030 |
Why?
|
| Hyperlipidemias | 1 | 2016 | 789 | 0.030 |
Why?
|
| Pregnancy | 2 | 2017 | 29144 | 0.020 |
Why?
|
| Cell Count | 1 | 2013 | 1856 | 0.020 |
Why?
|
| Hyperglycemia | 1 | 2016 | 1373 | 0.020 |
Why?
|
| Research Design | 1 | 2023 | 5987 | 0.020 |
Why?
|
| Electroencephalography | 1 | 2012 | 6150 | 0.020 |
Why?
|
| Weight Gain | 1 | 2016 | 2292 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2023 | 19905 | 0.020 |
Why?
|
| Dietary Supplements | 1 | 2016 | 3297 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2014 | 10943 | 0.010 |
Why?
|
| Age Factors | 1 | 2013 | 18370 | 0.010 |
Why?
|
| Obesity | 1 | 2016 | 12745 | 0.010 |
Why?
|
| Aged | 1 | 2022 | 163280 | 0.010 |
Why?
|